NL-OMON33656已完成3 期
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired renal function - Firefly
Schering-Plough0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Creatinine clearance (CLCR) < 30 mL/min for severe renal impairment group, CLCR >= 80 mL/min for control group
排除标准
- •Known or suspected allergy to narcotics, muscle relaxants or other medication used during general anesthesia
研究者
相似试验
进行中（未招募）
1 期
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired renal functioEUCTR2007-006935-29-FRV Organon70
进行中（未招募）
不适用
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired renal functioot applicableEUCTR2007-006935-29-NLOrganon Nederland BV70
进行中（未招募）
1 期
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of Org 25969 in subjects with normal or impaired renal function. - Springot ApplicableEUCTR2005-005050-47-GBV Organon30
进行中（未招募）
不适用
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired renal functioot applicableEUCTR2007-006935-29-ATV Organon70
进行中（未招募）
不适用
A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of Org 25969 in subjects with normal or impaired renal function. - Springot ApplicableEUCTR2005-005050-47-DEV Organon30